| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -1.1% |
| Cost of Revenue | $2.0M | -6.9% |
| R&D Expense | $3.3M | -26.7% |
| SG&A Expense | $5.8M | -9.4% |
| Operating Income | -$8.2M | +19.0% |
| Net Income | -$6.8M | +30.2% |
| EPS (Basic) | -$0.24 | +29.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.5M | +12.4% |
| Accounts Receivable | $466K | +41.3% |
| Current Assets | $8.1M | -39.9% |
| Total Assets | $8.2M | -40.1% |
| Current Liabilities | $2.3M | -8.0% |
| Total Liabilities | $2.3M | -10.8% |
| Stockholders' Equity | $5.9M | -47.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +16.8% |
| Investing Cash Flow | $7.4M | +414.4% |
| Financing Cash Flow | $0 | -100.0% |